US Stock MarketDetailed Quotes
RCKT Rocket Pharmaceuticals
- 11.560
- +0.210+1.85%
Close Dec 20 16:00 ET
- 11.700
- +0.140+1.21%
Post 20:01 ET
1.21BMarket Cap-4.23P/E (TTM)
11.790High11.150Low2.87MVolume11.310Open11.350Pre Close33.09MTurnover3.42%Turnover RatioLossP/E (Static)104.36MShares32.52552wk High3.66P/B969.18MFloat Cap11.15052wk Low--Dividend TTM83.84MShs Float67.480Historical High--Div YieldTTM5.64%Amplitude7.565Historical Low11.539Avg Price1Lot Size
About Rocket Pharmaceuticals Company
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Company Profile
SymbolRCKT
Company NameRocket Pharmaceuticals
Listing DateFeb 18, 2015
Issue Price6.00
Founded1999
CEODr. Gaurav Shah, M.D.
MarketNASDAQ
Employees268
Fiscal Year Ends12-31
Address9 Cedarbrook Drive
CityCranbury
ProvinceNew Jersey
CountryUnited States of America
Zip Code08512
Phone1-609-659-8001
Websitehttp://www.rocketpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Gaurav Shah, M.D.
- Director and Chief Executive Officer
- 8.01M
- Martin Wilson, J.D.
- Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Jonathan Schwartz, M.D.
- Chief Medical Officer and Chief Gene Therapy Officer
- 3.16M
- Aaron Ondrey
- Chief Financial Officer
- --
- Mayo Pujols
- Chief Technical Officer and Executive Vice President
- 4.38M
- Dr. Kinnari Patel, M.B.A.,Pharm.D.
- President, Chief Operating Officer and Head of R&D
- 4.85M
- Raj Prabhakar
- Chief Business Officer and Senior Vice President
- --
- Mark White
- General Manager, Commercial Affairs
- --
- John Militello, C.P.A.
- Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
- 1.53M
- Dr. Roderick Wong, M.D.
- Chairman of the Board
- 409.99K
- Dr. Mikael Dolsten, M.D.
- Director
- --
- David P. Southwell
- Independent Director
- 399.99K
- Dr. Gotham Makker, M.D.
- Independent Director
- 399.99K
- Dr. Fady Ibraham Malik, M.D.,PhD
- Independent Director
- 399.99K
- Robert Keith Woods
- Independent Director
- 568.70K
- Pedro P. Granadillo
- Independent Director
- 429.98K
- Carsten Boess
- Independent Director
- 427.49K
- Dr. Naveen Yalamanchi, M.D.
- Independent Director
- 417.49K
- Dr. Elisabeth Bjork, M.D.,PhD
- Independent Director
- 409.99K
Heat List
US
Overall
Symbol
Price
% Chg
No Data